Status:
COMPLETED
Vitamin D Supplementation in Patients With COVID-19
Lead Sponsor:
University of Sao Paulo
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Coronavirus disease 2019 (COVID-19) was declared an emergency public health problem by the World Health Organization (WHO) in March 2020. Since then, several initiatives by the medical and scientific ...
Eligibility Criteria
Inclusion
- Diagnosis of flu syndrome with hospitalization criteria;
- Respiratory rate ≥ 24irpm and / or saturation \<93% in room air, or belonging to the risk group for complications: 1. Chronic diseases: heart disease, diabetes mellitus, systemic arterial hypertension and neoplasms, 2. Immunosuppression, 3. Pulmonary tuberculosis; 4. Obesity;
- Tomographic findings compatible with coronavirus disease.
Exclusion
- Patient admitted already under invasive mechanical ventilation;
- Patient admitted with severe acute respiratory syndrome and diagnosed with an etiologic agent other than SARS-CoV-2;
- Prior vitamin D supplementation (above 1000 IU/day);
- Renal failure requiring dialysis or creatinine ≥ 2.0mg/dl;
- Admitted patients with expected hospital discharge in less than 24 hours;
- Patient unable to sign the consent form.
Key Trial Info
Start Date :
June 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 7 2020
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT04449718
Start Date
June 1 2020
End Date
October 7 2020
Last Update
November 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Hospital of the School of Medicine, University of Sao Paulo
São Paulo, Brazil, 05403-000